This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ASML Announces 2012 Fourth Quarter And Full Year Results In Line With Guidance

ASML – Reconciliation U.S. GAAP – IFRS 1,2

Net income   Three months ended,     Twelve months ended,
Dec 31,   Dec 31, Dec 31,   Dec 31,
2012 2011 2012 2011
(in millions EUR)                    
Net income based on U.S. GAAP 297.7 284.7 1,146.3 1,467.0
Development expenditures (see Note 1) 41.1 25.8 164.8 (2.2)
Share-based payments (see Note 2) (1.4) 0.3 (1.0) (0.3)
Reversal of write-downs (see Note 3) (14.0) 3.4 (7.2) 4.6
Income taxes (see Note 4)   (2.6)   2.8       (0.6)   24.9
Net income based on IFRS 320.8 317.0 1,302.3 1,494.0
 
 
Shareholders’ equity Dec 31, Sep 30, Jul 1, Apr 1, Dec 31,
2012 2012 2012 2012 2011
(in millions EUR)                    
Shareholders’ equity based on U.S. GAAP 4,066.9 6,905.7 3,595.5 3,612.0 3,444.2
Development expenditures (see Note 1) 396.8 356.6 308.7 267.3 233.0
Share-based payments (see Note 2) 4.1 4.1 4.0 3.7 2.7
Reversal of write-downs (see Note 3) - 14.0 14.4 6.5 7.2
Income taxes (see Note 4)   30.4   35.0   36.4   31.4   32.7
Equity based on IFRS 4,498.2 7,315.4 3,959.0 3,920.9 3,719.8

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Development expenditures

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures that are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production.

9 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs